A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Treatment Regimen of ST266 in Subjects With Moderate to Severe Periodontitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2016
At a glance
- Drugs ST 266 (Primary)
- Indications Periodontitis
- Focus Therapeutic Use
- Sponsors Noveome
- 13 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 02 May 2016 Status changed from planning to recruiting.
- 19 Apr 2016 New trial record